Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Echtrosept is a homeopathic combination medicinal product developed by Weber & Weber Biologische Arzneimittel. It is primarily indicated for the supportive treatment of acute and chronic infections, particularly those affecting the respiratory tract. The formulation is composed of several natural active ingredients, including *Echinacea purpurea* (Purple coneflower), *Baptisia tinctoria* (Wild indigo), *Thuja occidentalis* (Northern white-cedar), and *Lachesis mutus* (Bushmaster venom). These components are traditionally utilized in biological medicine to stimulate the body's non-specific immune defenses and modulate inflammatory processes. As a natural medicine, Echtrosept is designed to enhance the body's self-healing capabilities during infectious states and is typically administered as an oral solution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Echtrosept.